Peanut Allergy Clinical Trial Questionnaire
Thank you for your interest. This is a Phase II clinical study to find out if an investigational drug could prevent severe allergic reactions in people with Peanut Allergy and aged 18-55.
This study will last up to 3 months, with a 1-month treatment stage. The investigational drug is a twice-daily oral pill.
To see if you qualify for this trial, please take 5 minutes to complete the questionnaire below. Completing this online questionnaire does NOT obligate you to participate in the peanut allergy clinical trial.